Loading...
•
Sep 30, 2024
Inspire Q3 2024 Earnings Report
Reported a strong third quarter with significant revenue growth and improved operating leverage.
Key Takeaways
Inspire Medical Systems reported a 33% year-over-year revenue increase to $203.2 million and earnings per share of $0.60 in the third quarter of 2024. The company is increasing its full year revenue guidance to $793 million to $798 million and raising its full year earnings per share guidance to $1.20 to $1.40.
Generated revenue of $203.2 million, a 33% increase year-over-year.
Achieved a gross margin of 84.1%.
Reported operating income of $14.3 million and earnings per share of $0.60.
Activated 66 new U.S. centers, bringing the total to 1,371.
Revenue by Geographic Location
Forward Guidance
Inspire is increasing its full year 2024 revenue guidance to between $793 million to $798 million and increasing diluted net income per share guidance for the full year 2024 to between $1.20 to $1.40.
Positive Outlook
- Full year 2024 revenue guidance increased to $793 million - $798 million.
- Full year 2024 gross margin guidance maintained at 83% - 85%.
- Full year 2024 diluted net income per share guidance increased to $1.20 - $1.40.
- Guidance relating to the opening of new U.S. medical centers maintained at 52 to 56 per quarter.
- Guidance of 12 to 14 new U.S. territories for the fourth quarter of 2024 maintained.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...